TickerFactsScreenerDevelopers

Protara Therapeutics, Inc. (TARA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$8.00M2013: -$7.12M2014: -$7.58M2015: -$20.87M2016: -$28.70M2017: -$30.36M2018: -$21.37M2019: -$7.83M2020: -$34.44M2021: -$47.49M2022: -$67.06M2023: -$43.61M2024: -$49.15M2025: -$64.55M-$64.55M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$64.55M-31.3%
2024-$49.15M-12.7%
2023-$43.61M+35.0%
2022-$67.06M-41.2%
2021-$47.49M-37.9%
2020-$34.44M-339.9%
2019-$7.83M+63.4%
2018-$21.37M+29.6%
2017-$30.36M-5.8%
2016-$28.70M-37.5%
2015-$20.87M-175.3%
2014-$7.58M-6.4%
2013-$7.12M+10.9%
2012-$8.00M—